Category Archives: Drug Side Effects

Tecentriq Side Effects

Published by:

Tecentriq Side Effects: The U.S. Food and Drug Administration has given the thumbs up to Tecentriq (atezolizumab) as a treatment medication for urothelial carcinoma, the most common type of bladder cancer.

What are the side effects of the newly approved prescription medication? The most common Tecentriq side effects are feeling tired, decreased appetite, nausea, urinary tract infection, fever, and constipation.

Meantime, less common but serious side effects are as follows: Continue reading





Steroid Gynecomastia: Corrective Surgery for Guillermo Eiland – Before and After

Published by:

Steroid Gynecomastia Corrective Surgery for Guillermo Eiland. Did you know that use of steroids can lead to “manbreasts”? This is the case for 1990s rapper Guillermo Eiland, of the rap group Bone Thugs n Harmony, who was recently featured on the E! television show, Botched, about patients who have to undergo corrective procedures for their previous botched surgeries.

According to the show, Eiland began to develop breasts after years of steroid use. He underwent surgery to reduce the size of his chest but his original surgeon was not up to the task as the procedure left him with a lot of loose skin and sagging breast tissues. Fortunately for Guillermo, he was able to participate in the Botched reality show where Dr. Terry Dubrow managed to rectify the rapper’s condition.

Continue reading





Generic Copaxone Side Effects: Weight Gain, Painful Urination, Double Vision

Published by:

Is generic Copaxone as good as brand name Copaxone? The answer is a big fat yes according to the Food and Drug Administration (FDA):

Health care professionals and patients can be assured that FDA-approved generic drugs have met the same rigorous standards of quality as the brand-name drug. Before approving this generic product, given its complexity, we reviewed additional information to make sure that the generic product is as safe and effective as the brand name product. — Janet Woodcock, M.D., director of the FDA Center for Drug Evaluation and Research

Ms. Woodcock issued the above statement following her agency’s approval of the first generic version of Copaxone (glatiramer acetate injection) which is used to treat patients with multiple sclerosis.

Continue reading